Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON59707Phase 4Completed
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Digoxin with Placebo (2 arms). Primary endpoint: Primary composite endpoint. Started Nov 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON59707.